Veradermics has announced that its hair loss drug has succeeded in late-stage trials, marking a significant milestone for the company.
As one of the more advanced players in the hair loss treatment sector, Veradermics is benefiting from a notable increase in investor interest.
The results of this trial could potentially impact the competitive landscape of hair loss treatments, which has been gaining traction recently.